Pancreatic cancer mortality in Egypt

Comparison to the United States pancreatic cancer mortality rates

Amr S Soliman, Qing Zhang, Thanaa Saleh, Ali Zarzour, Mohei Selim, Mahmoud Abdel-Fattah, James L. Abbruzzese

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: Little is known about the descriptive epidemiology of pancreatic cancer in many developing countries, such as Egypt. It is believed to be rare in developing countries, but this may reflect lack of systematic cancer registration. Mortality may serve as a surrogate for incidence, since the disease is lethal. Because of availability of reliable mortality registration in Egypt, we used the national mortality data to estimate pancreatic cancer mortality in 2765 deaths from 2000 to 2004, and to gain insights into the disease incidence. Methods: Mortality data in Egypt was obtained from the electronic national mortality records of the Ministry of Health. We calculated population-based age-specific and age-standardized pancreatic cancer mortality rates for Egypt, and compared them with the Surveillance, Epidemiology, and End Results (SEER) mortality data of the United States. Results: Comparisons of age-specific mortality demonstrated higher rates in Egypt compared to the United States for subjects under age 20 years (relative risks (RR) of 7.7 and 4.2, for the age groups 0-15 and 15-20, respectively), and significantly higher rates in the United States compared to Egypt for subjects 40 years and older (RR 1.8-80.5 for the age groups of 40-45 to 75+). For the majority of age groups in Egypt and the United States, mortality in males was higher than in females. Analysis of regional distribution of pancreatic cancer mortality in Egypt showed significant variations in rates among provinces (p < 0.0001) with Northern provinces having average rate that is 2.85 times the rate of Southern provinces. The highest mortality rates were observed in the Nile Delta compared to southern Egypt and the oasis. Conclusions: The findings of this study demonstrate both international and regional variation in pancreatic cancer mortality, and highlight the importance of further investigation to explore the possible factors that may contribute to the observed epidemiological patterns.

Original languageEnglish (US)
Pages (from-to)473-479
Number of pages7
JournalCancer Detection and Prevention
Volume30
Issue number5
DOIs
StatePublished - Nov 20 2006

Fingerprint

Egypt
Pancreatic Neoplasms
Mortality
Age Groups
Developing Countries
Epidemiology
Incidence

Keywords

  • ANOVA and Tukey comparison test
  • Age-specific mortality
  • Age-specific rates
  • Cigarette smoking
  • Developing countries
  • Diet
  • Environmental exposures
  • Etiological factors
  • Gene-environment interactions
  • Geographic variation
  • Mortality
  • Occupation
  • Pancreatic cancer
  • SEER
  • Sex-specific mortality
  • Susceptibility
  • Validation process

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Soliman, A. S., Zhang, Q., Saleh, T., Zarzour, A., Selim, M., Abdel-Fattah, M., & Abbruzzese, J. L. (2006). Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates. Cancer Detection and Prevention, 30(5), 473-479. https://doi.org/10.1016/j.cdp.2006.06.006

Pancreatic cancer mortality in Egypt : Comparison to the United States pancreatic cancer mortality rates. / Soliman, Amr S; Zhang, Qing; Saleh, Thanaa; Zarzour, Ali; Selim, Mohei; Abdel-Fattah, Mahmoud; Abbruzzese, James L.

In: Cancer Detection and Prevention, Vol. 30, No. 5, 20.11.2006, p. 473-479.

Research output: Contribution to journalArticle

Soliman, AS, Zhang, Q, Saleh, T, Zarzour, A, Selim, M, Abdel-Fattah, M & Abbruzzese, JL 2006, 'Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates', Cancer Detection and Prevention, vol. 30, no. 5, pp. 473-479. https://doi.org/10.1016/j.cdp.2006.06.006
Soliman, Amr S ; Zhang, Qing ; Saleh, Thanaa ; Zarzour, Ali ; Selim, Mohei ; Abdel-Fattah, Mahmoud ; Abbruzzese, James L. / Pancreatic cancer mortality in Egypt : Comparison to the United States pancreatic cancer mortality rates. In: Cancer Detection and Prevention. 2006 ; Vol. 30, No. 5. pp. 473-479.
@article{6d24a331f95a4937a1db60d454421ffc,
title = "Pancreatic cancer mortality in Egypt: Comparison to the United States pancreatic cancer mortality rates",
abstract = "Objectives: Little is known about the descriptive epidemiology of pancreatic cancer in many developing countries, such as Egypt. It is believed to be rare in developing countries, but this may reflect lack of systematic cancer registration. Mortality may serve as a surrogate for incidence, since the disease is lethal. Because of availability of reliable mortality registration in Egypt, we used the national mortality data to estimate pancreatic cancer mortality in 2765 deaths from 2000 to 2004, and to gain insights into the disease incidence. Methods: Mortality data in Egypt was obtained from the electronic national mortality records of the Ministry of Health. We calculated population-based age-specific and age-standardized pancreatic cancer mortality rates for Egypt, and compared them with the Surveillance, Epidemiology, and End Results (SEER) mortality data of the United States. Results: Comparisons of age-specific mortality demonstrated higher rates in Egypt compared to the United States for subjects under age 20 years (relative risks (RR) of 7.7 and 4.2, for the age groups 0-15 and 15-20, respectively), and significantly higher rates in the United States compared to Egypt for subjects 40 years and older (RR 1.8-80.5 for the age groups of 40-45 to 75+). For the majority of age groups in Egypt and the United States, mortality in males was higher than in females. Analysis of regional distribution of pancreatic cancer mortality in Egypt showed significant variations in rates among provinces (p < 0.0001) with Northern provinces having average rate that is 2.85 times the rate of Southern provinces. The highest mortality rates were observed in the Nile Delta compared to southern Egypt and the oasis. Conclusions: The findings of this study demonstrate both international and regional variation in pancreatic cancer mortality, and highlight the importance of further investigation to explore the possible factors that may contribute to the observed epidemiological patterns.",
keywords = "ANOVA and Tukey comparison test, Age-specific mortality, Age-specific rates, Cigarette smoking, Developing countries, Diet, Environmental exposures, Etiological factors, Gene-environment interactions, Geographic variation, Mortality, Occupation, Pancreatic cancer, SEER, Sex-specific mortality, Susceptibility, Validation process",
author = "Soliman, {Amr S} and Qing Zhang and Thanaa Saleh and Ali Zarzour and Mohei Selim and Mahmoud Abdel-Fattah and Abbruzzese, {James L.}",
year = "2006",
month = "11",
day = "20",
doi = "10.1016/j.cdp.2006.06.006",
language = "English (US)",
volume = "30",
pages = "473--479",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Pancreatic cancer mortality in Egypt

T2 - Comparison to the United States pancreatic cancer mortality rates

AU - Soliman, Amr S

AU - Zhang, Qing

AU - Saleh, Thanaa

AU - Zarzour, Ali

AU - Selim, Mohei

AU - Abdel-Fattah, Mahmoud

AU - Abbruzzese, James L.

PY - 2006/11/20

Y1 - 2006/11/20

N2 - Objectives: Little is known about the descriptive epidemiology of pancreatic cancer in many developing countries, such as Egypt. It is believed to be rare in developing countries, but this may reflect lack of systematic cancer registration. Mortality may serve as a surrogate for incidence, since the disease is lethal. Because of availability of reliable mortality registration in Egypt, we used the national mortality data to estimate pancreatic cancer mortality in 2765 deaths from 2000 to 2004, and to gain insights into the disease incidence. Methods: Mortality data in Egypt was obtained from the electronic national mortality records of the Ministry of Health. We calculated population-based age-specific and age-standardized pancreatic cancer mortality rates for Egypt, and compared them with the Surveillance, Epidemiology, and End Results (SEER) mortality data of the United States. Results: Comparisons of age-specific mortality demonstrated higher rates in Egypt compared to the United States for subjects under age 20 years (relative risks (RR) of 7.7 and 4.2, for the age groups 0-15 and 15-20, respectively), and significantly higher rates in the United States compared to Egypt for subjects 40 years and older (RR 1.8-80.5 for the age groups of 40-45 to 75+). For the majority of age groups in Egypt and the United States, mortality in males was higher than in females. Analysis of regional distribution of pancreatic cancer mortality in Egypt showed significant variations in rates among provinces (p < 0.0001) with Northern provinces having average rate that is 2.85 times the rate of Southern provinces. The highest mortality rates were observed in the Nile Delta compared to southern Egypt and the oasis. Conclusions: The findings of this study demonstrate both international and regional variation in pancreatic cancer mortality, and highlight the importance of further investigation to explore the possible factors that may contribute to the observed epidemiological patterns.

AB - Objectives: Little is known about the descriptive epidemiology of pancreatic cancer in many developing countries, such as Egypt. It is believed to be rare in developing countries, but this may reflect lack of systematic cancer registration. Mortality may serve as a surrogate for incidence, since the disease is lethal. Because of availability of reliable mortality registration in Egypt, we used the national mortality data to estimate pancreatic cancer mortality in 2765 deaths from 2000 to 2004, and to gain insights into the disease incidence. Methods: Mortality data in Egypt was obtained from the electronic national mortality records of the Ministry of Health. We calculated population-based age-specific and age-standardized pancreatic cancer mortality rates for Egypt, and compared them with the Surveillance, Epidemiology, and End Results (SEER) mortality data of the United States. Results: Comparisons of age-specific mortality demonstrated higher rates in Egypt compared to the United States for subjects under age 20 years (relative risks (RR) of 7.7 and 4.2, for the age groups 0-15 and 15-20, respectively), and significantly higher rates in the United States compared to Egypt for subjects 40 years and older (RR 1.8-80.5 for the age groups of 40-45 to 75+). For the majority of age groups in Egypt and the United States, mortality in males was higher than in females. Analysis of regional distribution of pancreatic cancer mortality in Egypt showed significant variations in rates among provinces (p < 0.0001) with Northern provinces having average rate that is 2.85 times the rate of Southern provinces. The highest mortality rates were observed in the Nile Delta compared to southern Egypt and the oasis. Conclusions: The findings of this study demonstrate both international and regional variation in pancreatic cancer mortality, and highlight the importance of further investigation to explore the possible factors that may contribute to the observed epidemiological patterns.

KW - ANOVA and Tukey comparison test

KW - Age-specific mortality

KW - Age-specific rates

KW - Cigarette smoking

KW - Developing countries

KW - Diet

KW - Environmental exposures

KW - Etiological factors

KW - Gene-environment interactions

KW - Geographic variation

KW - Mortality

KW - Occupation

KW - Pancreatic cancer

KW - SEER

KW - Sex-specific mortality

KW - Susceptibility

KW - Validation process

UR - http://www.scopus.com/inward/record.url?scp=33750974476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750974476&partnerID=8YFLogxK

U2 - 10.1016/j.cdp.2006.06.006

DO - 10.1016/j.cdp.2006.06.006

M3 - Article

VL - 30

SP - 473

EP - 479

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 5

ER -